SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The objective of the study is to compare angiographic outcomes of Selution sirolimus coated balloon (MedAlliance) versus SeQuent Please Neo paclitaxel coated balloon (Bbraun) for the treatment of de novo coronary artery lesions in medium size vessels (\>2.00 mm and ≤3.00 mm) with respect to Net Gain (mm) and Fractional Flow Reserve (FFR) at 12 months follow-up.
Epistemonikos ID: 2c9f2d1e7f286e904b487f8ba2e5378839d96e48
First added on: May 15, 2024